ArticleWorld journal of urology2024

Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols.

Reuben Ben-David et al.PubMed ↗Publisher ↗

No numbers read from the abstract.